Search
Qiagen NV
QGENAdd to Watchlist
40.100USD
+0.980+2.50%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
8.27BMarket Cap
21.46P/E TTM
More Details of Qiagen NV Company
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Qiagen NV Info
Ticker SymbolQGEN
Company nameQiagen NV
IPO dateSep 01, 1996
CEOBernard (Thierry)
Number of employees5765
Security typeOrdinary Share
Fiscal year-endSep 01
AddressHulsterweg 82
CityVENLO
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryNetherlands
Postal code5912 PL
Phone31773556600
Websitehttps://www.qiagen.com/
Ticker SymbolQGEN
IPO dateSep 01, 1996
CEOBernard (Thierry)
Company Executives of Qiagen NV
Name
Name/Position
Position
Shareholding
Change
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
374.74K
+20.87%
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
349.19K
-4.22%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
167.23K
+2.41%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
49.12K
+8.67%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
15.46K
+23.57%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.77K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
22.00
-4.55%
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Eva Pisa, Ph.D.
Dr. Eva Pisa, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert van Meurs
Mr. Bert van Meurs
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
374.74K
+20.87%
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
349.19K
-4.22%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
167.23K
+2.41%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
49.12K
+8.67%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
15.46K
+23.57%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.77K
--
FAQs
Who are the top five shareholders of Qiagen NV?
The top five shareholders of Qiagen NV are: Mr. Thierry Bernard
How many institutions hold shares of Qiagen NV (QGEN)?
As of 2026Q1, 1005 institutions hold shares of Qiagen NV, with a combined market value of approximately 161.40M, accounting for 78.32% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -30070961.00.
What is the biggest source of revenue for Qiagen NV?
In 2026Q1, the Consumables and Related Revenues business generated the highest revenue for Qiagen NV, amounting to 1.88B and accounting for 89.78% of total revenue.